In Vitro Diagnostics (IVD) Market Size, Share & Trends Report

In Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report By Product, By Technology (Immunoassay, Molecular Diagnostics), By Application (Infectious Disease, Oncology/Cancer), By End Use, And Segment Forecasts, 2019 - 2026

  • Published Date: Apr, 2019
  • Base Year for Estimate: 2018
  • Report ID: 978-1-68038-080-4
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2017
  • Number of Pages: 159

Industry Insights

The global In Vitro Diagnostics market size was valued at USD 69.6 billion in 2018 and is estimated to register a CAGR of 4.75% from 2019 to 2026. Growing geriatric population, which is susceptible to various diseases and requires regular diagnostic tests, is expected to be one of the high impact rendering drivers for the market. Furthermore, new product launch and technological developments, in terms of cost-effectiveness, accuracy, and portability, are expected to propel the market growth over the forecast years.

For instance, in December 2018, Novacyt launched its new CE-IVD mark molecular diagnostic kits called Genesig Real-Time PCR Epstein-Barr Virus (EBV) Kit and Genesig Real-Time PCR BK virus (BKV) Kit. In addition, in July 2018, Surmodics, Inc., launched an assay “MatrixGuard Diluent” to reduce false positive results in IVD tests. Rising prevalence of various diseases, such as cancer, autoimmune diseases, and inflammatory diseases, is expected to drive the demand for IVD testing.

U.S. In Vitro Diagnostics (IVD) market

For instance, according to National Institute of Health (NIH), in 2017, approximately 23.5 Million cases of autoimmune diseases were reported in America and this number is expected to increase over the forecast period. Increasing tobacco and alcohol consumption, sedentary lifestyle, unhealthy dietary habits, etc. are the major factors responsible for increased prevalence of cancer. The number of cancer cases is expected to increase in low- and middle-income countries owing to lack of advanced healthcare infrastructure and availability of resources.

Rising demand for Point-of-Care (PoC) devices is expected to fuel the market growth further. In addition, introduction of advanced technologies, such as biochips and nano-biotechnology, and miniaturization of microfluidics are expected to increase the demand for PoC products. These advancements have enabled easy access to PoC diagnostic tests and are likely to facilitate quick and effective test results, thereby boosting the overall market growth.

Product Insights

On the basis of product, the market is segmented into instruments, reagents, and services. Reagents was the dominant product segment in 2018 due to high usage of these products in IVD testing. Rise in the number of R&D initiatives related to reagents and demand for self-test and PoC devices are also likely to boost the segment growth. On the other hand, instruments are expected to witness the highest CAGR during the forecast period. In April 2018, Altona Diagnostics GmbH, launched a CE-IVD marked AltoStar Molecular Diagnostics Workflow. It is a flexible and efficient automatic system that automates the entire workflow from sample preparation till analysis.

Technology Insights

On the basis of technology, market is segmented into immunoassay, clinical chemistry, hematology, molecular diagnostics, microbiology, coagulation, and others. Immunoassay led global market in 2018. Increasing incidence of chronic and communicable diseases and rising need for early diagnosis are the key factors attributed to the largest share of this technology segment. Molecular diagnostics is expected to witness the fastest CAGR over the forecast period. Molecular diagnostics enables early detection of cancer, infectious diseases, and genetic disorders by using genetic technologies and has applications in detection of abnormalities in the prenatal stage.

Application Insights

On the basis of application, the market is segmented into infectious disease, cardiology diabetes, cancer, drug testing, nephrology, autoimmune diseases, and others. The infectious disease segment dominated the market with a revenue of around USD 17 billion in 2018. Oncology is expected to be the fastest-growing application segment during the forecast years. The segment is driven by several factors, such as increasing demand for self-care devices and POC diagnostics, for the treatment of chronic diseases.

End Use Insights

On the basis of end use, the market is segmented into hospitals, laboratories, home care, and others. IVD services are used by hospitals and laboratories as well as directly by patients.

Global In Vitro Diagnostics (IVD) market

Hospitals segment accounted for the largest share of 45.68% in 2018, owing to high demand for IVD tests as a result of rise in hospitalization, whereas homecare is expected to be the fastest-growing segment over the forecast period.

Regional Insights

North America held the largest market share of 46.23% in 2018. Favorable government regulations, well-established diagnostic infrastructure, technological advancements, and presence of key market participants in this region are the factors responsible for its largest share.

On the other hand, Asia Pacific is expected to witness the fastest growth over the forecast period. Presence of target population base and rapidly improving healthcare infrastructure in Asia Pacific are anticipated to boost the market growth over the next few years.

In Vitro Diagnostics (IVD) Market Share Insights

Some of the key companies in the global market are Siemens Healthineers; Qiagen; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.; bioMerieux SA; Hologic, Inc. (Gen-Probe); Abbott Laboratories; Danaher Corp.; Sysmex Corp.; and Cepheid, Inc.

These companies focus on strategies, such as M&A, collaborations, and new product developments to strengthen their global reach and increase market share. For instance, in August 2018, Sysmex Corp. and JVCKENWOOD Corp. jointly established a new company “Creative Nanosystems Corp.” to develop and manufacture biodevices.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2017

Forecast period

2019 - 2026

Market representation

Revenue in USD Million and CAGR from 2018 to 2026

Regional scope

North America, Europe, Asia Pacific, Latin America, and MEA

Country scope

U.S., Canada, U.K., Germany, Spain, France, Italy, Russia, Japan, China, India, South Korea, Singapore, Australia, Brazil, Mexico, Argentina, South Africa, UAE, and Saudi Arabia

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope(equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global In Vitro Diagnostics (IVD) market report on the basis of product, technology, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2026)

    • Instruments

    • Reagents

    • Services

  • Technology Outlook (Revenue, USD Million, 2014 - 2026)

    • Immunolo

      • Instruments

      • Reagents

      • Services

    • Hematology

      • Instruments

      • Reagents

      • Services

    • Clinical Chemistry

      • Instruments

      • Reagents

      • Services

    • Molecular Diagnostics

      • Instruments

      • Reagents

      • Services

    • Coagulation

      • Instruments

      • Reagents

      • Services

    • Microbiology

      • Instruments

      • Reagents

      • Services

    • Others

      • Instruments

      • Reagents

      • Services

  • Application Outlook (Revenue, USD Million, 2014 - 2026)

    • Infectious Disease

    • Diabetes

    • Oncology

    • Cardiology

    • Nephrology

    • Autoimmune Diseases

    • Drug Testing

    • Others

  • End Use Outlook (Revenue, USD Million, 2014 - 2026)

    • Hospitals

    • Laboratories

    • Home Care

    • Others

  • Regional Outlook (Revenue, USD Million, 2014 - 2026)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • Spain

      • France

      • Italy

      • Russia

    • Asia Pacific

      • Japan

      • China

      • India

      • South Korea

      • Singapore

      • Australia

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • MEA

      • South Africa

      • United Arab Emirates

      • Saudi Arabia

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified